Details for Patent: 9,517,207

Title:	Pharmaceutical formulation containing gelling agent
Abstract:	Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Inventor(s):	Wright; Curtis (Rockport, MA), Oshlack; Benjamin (Boca Raton, FL), Breder; Christopher (Bethesda, MD)
Assignee:	Purdue Pharma L.P. (Stamford, CT) The P.F. Laboratories, Inc. (Totowa, NJ) Purdue Pharmaceuticals L.P. (Wilson, NC)
Filing Date:	Sep 11, 2015
Application Number:	14/851,727
Claims:	1. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 13/726,324 on Jul. 15, 2013. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/243,580 on Oct. 2, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/243,580 on May 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/243,580 on Sep. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/460,134 on Oct. 2, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/460,170 on Oct. 2, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/460,170 on May 6, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/460,170 on Aug. 27, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/470,631 on Oct. 21, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/470,631 on May 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/470,662 on Nov. 4, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/470,662 on May 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/484,077 on Oct. 22, 2014. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/605,034 on Mar. 11, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/605,034 on Jul. 21, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/611,716 on Mar. 25, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/611,716 on Sep. 4, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/658,285 on Apr. 22, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/658,285 on Dec. 3, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/728,601 on Aug. 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/728,601 on Nov. 17, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,002 on Jul. 15, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,002 on Nov. 23, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,003 on Jul. 22, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,003 on Nov. 17, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,016 on Aug. 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,017 on Jul. 15, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,017 on Nov. 18, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,021 on Jul. 21, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/730,021 on Nov. 17, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,618 on Aug. 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,618 on Nov. 27, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,634 on Aug. 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,634 on Dec. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,639 on Jul. 21, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,639 on Dec. 1, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,647 on Aug. 28, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,647 on Dec. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,654 on Jul. 21, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,654 on Dec. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,659 on Aug. 5, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/733,659 on Dec. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/846,021 on Oct. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/851,575 on Dec. 4, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/852,157 on Dec. 4, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/852,236 on Dec. 16, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/856,386 on Nov. 2, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/856,388 on Nov. 4, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/856,392 on Oct. 21, 2015. cited by applicant . The Office Action issued in connection with U.S. Appl. No. 14/856,394 on Nov. 5, 2015. cited by applicant . IPR2016-01027, Petition for Inter Partes Review of U.S. Pat. No. 9,060,976), pp. 1-75, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1001, U.S. Pat. No. 9,060,976 (the '976 Patent), pp. 1-24, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1002, U.S. Pat. No. 8,337,888 (the '888 Patent), pp. 1-25, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1003, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 13-cv-3372-SHS (S.D.N.Y. Apr. 8, 2015.sub.-- Finding of Facts and Conclusions of Law ("SDNY Decsion"), pp. 1-69, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1004, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 2015-1654 (Fed. Cir. Apr. 8, 2016) Order ("Federal Circuit Decision"), pp. 1-2, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1005, U.S. Pat. No. 8,101,630 ("Kumar Patent"), pp. 1-21, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1006, U.S. Patent Publication No. 2010/0216829 ("Kumar Publication"), pp. 1-23, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1007, Complaint, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, 15-cv-831, filed Sep. 17, 2015, pp. 1- 9, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1008, Complaint, Purdue Pharma L.P. et al. V. Amneal Pharmaceuticlas LLC, 15-cv-1152, filed Dec. 15, 2015, pp. 1-36, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1009, Declaration of Dr. Anthony Palmieri ("Palmieri Declaration"), pp. 1-43, May 11, 2015. cited by applicant . IPR2016-01027, Exhibit 1010, Curriculum Vitae of Anthony Palmieri, Ph.D., pp. 1-13, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1011, International Publication No. WO 99/32120 ("Palermo"), pp. 1-47, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1012, The Handbook of Pharmaceuticals Excipients pp. 399-400,655 (3.sup.rd ed. 2000), pp. 1-5, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1013, International Publication No. WO 97/49384 ("McGinity"), pp. 1-29, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1014, U.S. Patent Publication No. 2002/0187192 ("Joshi"), pp. 1-6, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1015. International Publication No. WO 95/20947 ("Bastin"), pp. 1-39, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1016. OxyContin, Physicians' Desk Reference pp. 2569-2574 (53.sup.rd ed. 1999), pp. 1-8, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1017, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2014-1306, -1307 (Fed. Cir. Feb. 1, 2016), pp. 1-27, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1018, Department of Justice, Information Bulletin: OxyContin Diversion and Abuse (Jan. 2001), pp. 1-6, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1019, Barry Meier, U.S. Asks Painkiller Maker to Help Curb Wide Abuse, The New York Times (May 1, 2001), pp. 1-3, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1020, Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 2015-1654 (Fed. Cir. Aug. 12, 2015), pp. 1-198, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1021, Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 2015-1654 (Fed. Cir. Dec. 23, 2016), pp. 1-41, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1022, U.S. Appl. No. 13/726,324, Originally Filed Specification, Dec. 24, 2012, pp. 1-62, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1023, U.S. Appl. No. 13/349,449, Originally Filed Specification, Jan. 12, 2012, pp. 1-62, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1024, U.S. Appl. No. 12/653,115, Originally Filed Specification, Dec. 8, 2009, pp. 1-62, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1025, U.S. Appl. No. 10/214,412, Originally Filed Specification, Aug. 6, 2002, pp. 1-62, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1026, U.S. Appl. No. 60/310,534, pp. 1-64, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1028, U.S. Appl. No. 13/726,324, Preliminary Amendment, Dec. 24, 2012, pp. 1-8, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1029, U.S. Appl. No. 13/726,324, Supplemental Amendment, Jan. 23, 2013, pp. 1-10, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1030, U.S. Appl. No. 13/726,324, Office Action, Jul. 15, 2013, pp. 1-10, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1031, U.S. Appl. No. 13/726,324, Amendment and Response, Jan. 15, 2014, pp. 1-27, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1032, U.S. Appl. No. 13/726,324, Notice of Allowance, Oct. 31, 2014, pp. 1-8, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1033, U.S. Appl. No. 13/726,324, Request for Continued Examination, Jan. 5, 2015, pp. 1-3, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1034, U.S. Appl. No. 13/726,324, Communication from Applicant, Jan. 29, 2015, pp. 1 of1, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1035, U.S. Appl. No. 13/726,324, Information Disclosure Statement, Apr. 14, 2015, pp. 1-8, May 11, 2006. cited by applicant . IPR2016-01027, Exhibit 1036, U.S. Appl. No. 13/726,324, Notice of Allowance, May 12, 2015, pp. 1-9, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1037, U.S. Pat. No. 4,861,598 ("Oshlack"), pp. 1-5, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1038, U.S. Appl. No. 60/287,509 ("Josh Provisional"), pp. 1-14, May 11, 2016. cited by applicant . IPR2016-01027, Exhibit 1039, Oral Dosage Forms, II (94) Remington: The Science and Practice of Pharmacy 1666-69 (19.sup.th ed. 1995), pp. 1-9, May 11, 2016. cited by applicant . IPR2016-01028, Petition for Inter Partes Review of U.S. Pat. No. 9,060,976, pp. 1-76, May 11, 2016. cited by applicant . IPR2016-00849, Petition for Inter Partes Review of U.S. Pat. No. 8,383,007, pp. 1-73, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1001, U.S. Pat. No. 8,389,007 to Curtis Wright, Benjamin Oshlack, and Christopher Breder, issued on Mar. 5, 2013, pp. 1-24, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1002, Expert Declaration of Arthur H. Kibbe (Dated Apr. 6, 2016), pp. 1-140, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1003, U.S. Pat. No. 8,337,888 to Curtis Wright, Benjamin Oshlack, and Christopher Breder, issued on Dec. 25, 2012, pp. 1-25, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1004, Purdue Pharma L.P., et al. v. Amneal Pharmaceuticals, LLC, No. 13-cv-3372 (SHS) (S.D.N.Y. Apr. 8, 2015) (Findings of Fact and Conclusions of Law), pp. 1-69, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1005, Physician Desk Reference, 54.sup.th Edition (2000), pp. 1-15, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1006, U.S. Patent Application No. 2002/0187192 to Yatindra Joshi and Russell Somma, published on Dec. 12, 2012, pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1007, U.S. Appl. No. 60/287,509, filed Apr. 30, 2001, pp. 1-15, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1008, U.S. Patent Application No. 2003/0064122 to Michael Goldberg, Bradley Stuart Galer, Huai-Hung Kao, published on Apr. 3, 2003, pp. 1-7, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1009, U.S. Appl. No. 60/292,809, filed May 23, 2001, pp. 1-12, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1010, U.S. Pat. No. 5,183,654 to Ulrich Speck and Peter Blaszkiewicz, issued on Feb. 2, 1993, pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1011, U.S. Pat. No. 3,980,766 to irving F. Shaw and Jerome Berk, issued on Sep. 14, 1976, pp. 1-5, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1012, U.S. Pat. No. 4,070,494 to Friedrich Hoffmeister, Rudolf Hiltmann, Hardmund Wollweber, and Helmut Kramer, issued on Jan. 24, 1978, pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1013, U.S. Pat. No. 8,337,888 Prosecution File History (Notice of Allowance, filed Dec. 3, 2012), pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1014, U.S. Appl. No. 60/310,534, filed Aug. 6, 2001, pp. 1-67, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1015, Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2015-1654 (Fed. Cir. Aug. 12, 2015), pp. 1-198, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1016, Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2015-1654 (Fed. Cir. Dec. 23, 2016), pp. 1-41, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1017, Meier, "U.S. Asks Painkiller Maker to Help Curb Wide Abuse", NY times (May 1, 2001), pp. 1-3, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1018, Department of Justice, Information Bulletin: OxyContin Diversion and Abuse (Jan. 2001), pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1019, U.S. Pat. No. 6,309,663 to Mahesh V. Patel and Feng-Jing Chen, issued on Oct. 30, 2001, pp. 1-55, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1020, International patent application No. 99/44591 to David Edgren, Shu Li, Bhatti Gurdish, Patrick Wong and Robert Skluzacek, published on Sep. 10, 1999, pp. 1-57, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1021, U.S. Pat. No. 4,710,384 to Avner Rotman, issued on Dec. 1, 1987, pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1022, U.S. Patent Application No. 2002/0142039 to Charles David Claude, published on Oct. 3, 2002, pp. 1-9, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1023, Banker, Modern Pharmaceutics, 3.sup.rd Edition (1996), pp. 1-66, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1024, Kibbe, Handbook of Pharmaceutical Excipients, 3.sup.rd Edition (2000), pp. 1-18, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1025, U.S. Pat. No. 5,422,134 to Robert J. Hart, William M. Marrs, Judy A. White and Iain C. M. Dea, issued on Jun. 6, 1995, pp. 1-11, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1026, European Patent Application No. 0974345 to Young, Victor Morrison, pp. 1-4, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1027, Waugh, et. al., Peroperative Venography to Ensure Accurate Saphenopopliteal Vein Ligation, British Medical Journal (Jun. 28, 1090), pp. 1-2, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1028, Abdala, et al., Can HIV-1-Contaiminated Syringes Be Disinfected?, Journal of Acquired Immune Deficiency Syndromes 28:487-494 (2001), pp. 1-8, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1029, Needle, et al. HIV Risk Behaviors Associated with the Injection Process: Multiperson Use of Drug Injection Equipment and Paraphernalia in Injection Drug User Networks, Substance and Misuse 33:2401-2423 (1998), pp. 1-22, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1030, Neilloud, et al, Pharmaceutical Emulsions and Suspensions (2000), pp. 1-29, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1031, European Pat. No. 0828802 to Paul J. Northey, issued on Jun. 25, 2003, pp. 1-17, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1032, Buhler, Kollidon : Polyvinylpyrrolidone for the Pharmaceutical Industry, 4th Edition (1998), pp. 1-288, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1033, U.S. Pat. No. 4,737,151 to John G. Clement and David R. Harker. Issued on Apr. 12, 1988, pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1034, Chien, et al., Syringeability of Nonaqueous Parental Formulations--Development and Evaluation of a Testing Apparatus, PDA Journal of Science and Technology 35:281-284 (1981), pp. 1-6, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1035, Budavari, et al., The Merck Index, 12.sup.th Edition 1996, pp. 1-4, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1036, Maggi, et al. High Molecular Weight Polyethylene Oxides (PEOs) as an alternative to HPMC in controlled release dosage forms, International Journal of Pharmaceutics 195:229-238 (2000), pp. 1-10, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1037, The United States Pharmacopeia (2000), pp. 1-10, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1038, Mark, et al. Encyclopedia of Polymer Science and Engineering (1986), pp. 1-100, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1039, Poll, The Story of the Gauge, Anesthesia, 54:575-581, pp. 1-7, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1040, Bellingham, A reference Guide to insulin Pens, The Pharmaceutical Journal (Jun. 10, 2000), pp. 1-3, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1041, Purdue Pharma LP. et al. v. Acura Pharmaceuticals, Inc., 15-cv-00292-RGA (D.Del). (Egalet Proof Service), pp. 1-2, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1042, Purdue Pharma LP. et al. v. Acura Pharmaceuticals, Inc., 15-cv-00292-RGA (D.Del). (Acura Proof of Service), p. 1 of 1, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1043, Purdue Pharma LP., et al, v. Amneal Pharmaceuticals, LLC, No. 13-cv-3372 (SHS) (Trail Transcript on Jul. 14, 2014), pp. 1-198 Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1044, Bailey, et al. High Molecular Weight Polymers of Ethylene Oxide, Industrial and Engineering Chemistry 50:8-11 (1958), pp. 1-4, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1045, Gard, FDA Advisers Side Against Purdue's New Painkiller, Citing Dosing Dangers, FierceBiotech (Sep. 11, 2015), pp. 1-2, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1046, International Patent Application No. 96/106528 to James Ward, published on Mar. 7, 1996, pp. 1-66, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1047, International Patent Application 95/18602 to Mary Diabase and Howard Bernstein, published on Jul. 13, 1995, pp. 1-29, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1048, Markus, et al., Microscopic Air Embolism During Cerebral Angiography and Strategies for its Avoidance, The Lancet 341:784-87 (1993), pp. 1-4, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1049, U.S. Pat. No. 6,096,722 to C. Frank Bennett, Christopher K. Mirabelli, and Brenda Baker, issued on Aug. 1, 2000, pp. 1-85, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1050, Singh, et al. Transdermal Iontophoretic Delivery of Methylphenidate HCI in vitro, International Journal of Pharmaceutics 178:121-128 (1999), pp. 1-8, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1051, Webster's Third New International Dictionary (1986), pp. 1-3, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1052, Henderson's Dictionary of Biological Terms 10.sup.th Edition (1989), pp. 1-3, Apr. 6, 2016. cited by applicant . IPR2016-00849, Exhibit 1053, Apicella, et al., Poly(ethylene oxide) (PEO) and Different Molecular Weight PEO Blends Monolithic Devices for Drug Release, Biomaterials 14:83-90 (1993), pp. 1-9, Apr. 6, 2016. cited by applicant . In re Oxycontin Litigation, Case 14-1654, Document 78, p. 2, (CAFC Apr. 8, 2016). cited by applicant . Zasypkin et al. Multicomponent biopolymer gels. Food Hydrocolloids, 1997, vol. 11 No. 2 pp. 159-170. cited by applicant . Meunier. Mul Ticomponent Biopolymer Gels: The Agarose-Carrageenan-Gellan System. 3rd International Symposium on Food Rheology and Structure, 2003, Zurich, Switzerland, Proceedings 493-494. cited by applicant . Petition for Inter Partes Review, IPR2016-01412 of U.S. Pat. No. 9,034,376, dated Jul. 15, 2016, pp. 1-75. cited by applicant . Petition for Inter Partes Review, IPR2016-01413 of U.S. Pat. No. 9,034,376, dated Jul. 15, 2016, pp. 1-66. cited by applicant . Declaration of Dr. Anthony Palmieri for IPR2016-01412, dated Jul. 15, 2016, pp. 1-67. cited by applicant . Declaration of Dr. Anthony Palmieri for IPR2016-01413, dated Jul. 15, 2016, pp. 1-56. cited by applicant . Handbook of Pharmaceutical Excipients, pp. 252-255, 399-400, 655 (3rd ed. 2000). cited by applicant . CRC Handbook of Chemistry and Physics, p. F-56 (59th ed. 1978). cited by applicant . Opioid bill passes, but there's little money to act on its wish list, Politics & Government (Jul. 13, 2016), available at http://www.newsoberver.com/news/politics-government/article89403007.html (last visited Jul. 14, 2016), pp. 1-5. cited by applicant.

Primary Examiner: Buckley; Audrea
Attorney, Agent or Firm: Davidson, Davidson & Kappel, LLC